Mydecine Innovations Group Inc (MYCOF)

[StockHighAlert-]

The Newly is the first partner under $MYCOF Mydecine’s recently announced Special Access Support and Supply Program (SASSP). The companies will develop protocols and therapy manuals for a variety of indications. Mydecine will provide cGMP psilocybin and MDMA alongside the safety and efficacy data needed to gain acceptance into Health Canada’s SAP. The Newly will provide the clinic locations and experienced therapists needed to perform the treatments. The companies intend to enter into a revenue sharing agreement. https://www.mydecine.com/news-media/press-releases/detail/91/mydecine-to-launch-special-access-support-and-supply